President’s address: Treatment of tamoxifen-refractory breast cancer — approach by animal models Yuichi Iino EditorialNotes Pages: 262 - 264
New strategies for the treatment of breast cancer David J. BentremRuth M. O’ReganV. Craig Jordan OriginalPaper Pages: 265 - 274
Well differentiated clinging carcinoma and atypical ductal hyperplasia are synonymous Vincenzo EusebiStefano MignaniTetsunari Oyama OriginalPaper Pages: 283 - 284
E1A: Tumor suppressor or oncogene? Preclinical and clinical investigations ofE1A gene therapy Naoto T. UenoDihua YuMien-Chie Hung OriginalPaper Pages: 285 - 293
International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland Beat Thuerlimann OriginalPaper Pages: 294 - 297
Adjuvant therapy for breast cancer — results from the USA consensus conference Jeffrey S. Abrams OriginalPaper Pages: 298 - 304
Third-generation aromatase inhibitors in the treatment of advanced breast cancer Jean-Marc A. NabholtzDavid M. Reese OriginalPaper Pages: 305 - 309
Compassionate use of humanized anti-HER2/neu protein, trastuzumab for metastatic breast cancer in Japan Yutaka TokudaYasuhiro SuzukiR. Yoshiyuki Osamura OriginalPaper Pages: 310 - 315
Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab) Shinobu UmemuraGoi SakamotoR. Yoshiyuki Osamura OriginalPaper Pages: 316 - 320
The worldwide perspective in the adjuvant treatment of primary lymph node positive breast cancer Stefan Glück OriginalPaper Pages: 321 - 328
Aromatase and aromatase inhibitors Masakazu ToiHiroko BandoShigehira Saji OriginalPaper Pages: 329 - 332
Resistant mechanisms of anthracyclines — pirarubicin might partly break through the P-glycoprotein-mediated drug-resistance of human breast cancer tissues Tetsuro KubotaTomoko FurukawaMasaki Kitajima OriginalPaper Pages: 333 - 338
Evolution of breast cancer management: Focus on neoadjuvant chemotherapy Steven D. Heys OriginalPaper Pages: 339 - 350
3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: Clinical results and future perspectives with reference to FDG-PET Seigo NakamuraHironori KenjoKoyu Suzuki OriginalPaper Pages: 351 - 354